TINAG anticorps (Middle Region)
Aperçu rapide pour TINAG anticorps (Middle Region) (ABIN633037)
Antigène
Voir toutes TINAG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- TINAG antibody was raised against the middle region of TINAG
-
Purification
- Affinity purified
-
Immunogène
- TINAG antibody was raised using the middle region of TINAG corresponding to a region with amino acids VAADRIAIQSKGRYTANLSPQNLISCCAKNRHGCNSGSIDRAWWYLRKRG
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
TINAG Blocking Peptide, (ABIN5616610), is also available for use as a blocking control in assays to test for specificity of this TINAG antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TINAG antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TINAG (Tubulointerstitial Nephritis Antigen (TINAG))
-
Autre désignation
- TINAG
-
Sujet
- TINAG is a basement membrane glycoprotein initially identified as a target of antibodies in some forms of immunologically mediated tubulointerstitial nephritis.
-
Poids moléculaire
- 54 kDa (MW of target protein)
Antigène
-